Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Global Cord Blood Corp (CO)

Global Cord Blood Corp (CO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 324,541
  • Shares Outstanding, K 121,551
  • Annual Sales, $ 196,120 K
  • Annual Income, $ 79,040 K
  • 60-Month Beta 0.14
  • Price/Sales 1.61
  • Price/Cash Flow 3.82
  • Price/Book 0.42
Trade CO with:

Options Overview Details

View History
  • Implied Volatility 90.56% ( -12.78%)
  • Historical Volatility 80.95%
  • IV Percentile 66%
  • IV Rank 21.54%
  • IV High 319.05% on 07/19/22
  • IV Low 27.83% on 10/15/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 133
  • Volume Avg (30-Day) 60
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 1,936
  • Open Int (30-Day) 1,825

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.03 +31.53%
on 08/02/22
2.77 -3.61%
on 08/11/22
+0.09 (+3.49%)
since 07/12/22
3-Month
2.03 +31.53%
on 08/02/22
3.85 -30.65%
on 06/06/22
+0.23 (+9.43%)
since 05/12/22
52-Week
2.03 +31.53%
on 08/02/22
5.50 -51.45%
on 02/15/22
-2.08 (-43.79%)
since 08/12/21

Most Recent Stories

More News
Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

CO : 2.67 (+3.09%)
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

CO : 2.67 (+3.09%)
INCY : 73.99 (+0.31%)
This Diagnostic Testing Company Down 60% - Time to Buy?

Despite witnessing double-digit revenue growth in the last reported quarter Natera Inc. (NTRA) stock has plunged nearly 60% year-to-date. So, let’s evaluate if it is worth buying the stock now. Read...

A : 133.55 (+1.21%)
CO : 2.67 (+3.09%)
NTRA : 55.17 (+2.95%)
QGEN : 49.92 (+0.28%)
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

CO : 2.67 (+3.09%)
Shareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood Corporation

Blue Ocean Structure Investment Company Ltd., (“Blue Ocean”) and shareholders representing over 75% of the outstanding shares of Global Cord Blood Corporation (the “Company” or “Global Cord”)...

CO : 2.67 (+3.09%)
Shareholders of Global Cord Blood Corporation Are Reminded to Comply with the Rules of Conduct When Attending the Extraordinary General Meeting and Exercising Their Voting Rights

Blue Ocean Structure Investment Company Ltd.,(“Blue Ocean”) together with shareholders representing no less than 75% of the outstanding shares of Global Cord Blood Corporation (the “Company” or...

CO : 2.67 (+3.09%)
Is OPKO Health a Diagnostics Stock Worth Buying?

Multinational biopharmaceutical company OPKO Health's (OPK) stock climbed nearly 13% in price last year when the company announced its plans to acquire ModeX Therapeutics. However, given the company's...

A : 133.55 (+1.21%)
CO : 2.67 (+3.09%)
OPK : 2.52 (+0.80%)
QGEN : 49.92 (+0.28%)
Should You Scoop Up Shares of 23andMe?

23andMe (ME) saw its shares slump in price after it reported its fourth-quarter earnings results last month. However, given the company's multiple FDA authorizations for over-the-counter genetic health...

A : 133.55 (+1.21%)
CO : 2.67 (+3.09%)
ME : 5.12 (+9.17%)
QGEN : 49.92 (+0.28%)
Shareholders Led by Blue Ocean Call Extraordinary General Meeting of Global Cord Blood Corporation Shareholders to Terminate its Proposed Acquisition of Cellenkos, Inc. and Elect New Board

Blue Ocean Structure Investment Company Ltd.,(“Blue Ocean”) announced today that shareholders representing no less than 75% of the outstanding shares of Global Cord Blood Corporation (the “Company”...

CO : 2.67 (+3.09%)
Blue Ocean Announces Virgin Islands Court Grants Injunction Order Prohibiting Golden Meditech from Taking Any Steps on a Purported Share Charge from Blue Ocean or Pursuing the Removal of Blue Ocean’s Representative as a Director of Global Cord Blood

Blue Ocean Structure Investment Company Ltd. (“Blue Ocean”), a significant shareholder of Global Cord Blood Corporation (the “Company” or “Global Cord”) (NYSE: CO), today announced that the...

CO : 2.67 (+3.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood...

See More

Key Turning Points

3rd Resistance Point 2.83
2nd Resistance Point 2.75
1st Resistance Point 2.71
Last Price 2.67
1st Support Level 2.59
2nd Support Level 2.51
3rd Support Level 2.47

See More

52-Week High 5.50
Fibonacci 61.8% 4.17
Fibonacci 50% 3.76
Fibonacci 38.2% 3.36
Last Price 2.67
52-Week Low 2.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar